Independent model study · mammalian CDMO

Accept the next biologics campaign only when the whole facility fits

Test whether production reactors, downstream suites, buffer holds, WFI, changeovers, analytics or labour bind before a commercial slot is promised.
Accept the next biologics campaign only when the whole facility fits in the Acatian flowsheet workspace
One flowsheet connects assumptions, balances, equipment, time, economics and evidence.
SeedProductionHarvestCapturePolishUF/DFBulk fill

Decision model

A bounded question with a complete plant consequence.

Decision

Accept, defer or decline a candidate campaign—and identify whether another reactor, downstream asset, WFI expansion or changeover reduction creates the greatest capacity value.

System boundary

Inoculum through bulk drug substance, including media/buffer preparation, clean rooms, columns, tanks, WFI, CIP/SIP, cold storage, QC sampling and release holds.

Governing structure

Equations and accounting rules

01Batch output = working volume × titer × DSP yield
02Column load ≤ DBC × resin volume × safety utilisation
03One task per exclusive resource plus sequence-dependent setup cₚ,q,u
04OTIF = accepted lots delivered on time / accepted lots
Scenario set

Base, alternative and stress cases

  • Long campaigns versus frequent changeovers
  • New high-volume molecule in the demand mix
  • Production line outage or chromatography rework
  • Additional buffer tank, WFI or capture skid

Engineering brief

Model the complete decision, not an isolated unit operation.

Lonza publicly describes multi-product mammalian capacity at several scales, including 12,000 L and 25,000 L reactors. The study uses those public scale classes only to frame a reusable CDMO planning problem.

All molecule recipes, titers, customers, campaign orders, changeover matrices and utilisation values are synthetic. The model asks whether a candidate campaign is feasible, not whether any named facility has a problem.

01 · Model basis

What the Acatian model needs to resolve

Inputs, mechanisms, limits and outputs remain reviewable on one declared basis.

Inputs

Data

Product recipes, culture durations, titers and yields

Evidence

Equipment eligibility, campaign size and due dates

Plant

Buffer recipes, WFI draws and hold limits

Basis

Changeover, QC, labour and maintenance calendars

Mechanisms

Balance

Batch output = working volume × titer × DSP yield

Model

Column load ≤ DBC × resin volume × safety utilisation

System

One task per exclusive resource plus sequence-dependent setup cₚ,q,u

Time

OTIF = accepted lots delivered on time / accepted lots

Constraints

Limit

Suite segregation and cleaning validation

Risk

Buffer/WFI time-series inventory

Capacity

Column cycles, pool volumes and maximum holds

Gate

QC release, labour and maintenance availability

Outputs

Result

Feasible Gantt schedule and start date

Decision

Accepted kg, OTIF and late lots

Plant

Suite, WFI and buffer utilisation

Value

Contribution per constrained suite-hour

02 · Acatian workflow

Build it in six controlled steps

Each step creates a reviewable object, not a hidden spreadsheet assumption.
  1. 01

    Define the candidate contract and due-date window.

  2. 02

    Create product-specific recipes and resource eligibility.

  3. 03

    Close material, buffer and column-cycle balances.

  4. 04

    Apply cleaning, hold, QC and labour calendars.

  5. 05

    Solve alternative campaign sequences and outages.

  6. 06

    Return feasibility, bottleneck and data-gap evidence.

03 · Decisions

Questions the model should answer

Can the proposed campaign fit without breaking existing delivery?

Which shared resource controls the slot?

Is CAPEX or sequencing the better intervention?

What downside case should commercial terms recognise?

04 · Evidence boundary

Validate before the result carries weight

Validation

Verify material genealogy, equipment no-overlap, cleaning precedence, WFI inventory, hold compliance and schedule reproduction against authorised historical campaigns.

Limitations

No Lonza customer, recipe, utilisation, commercial slot or actual facility schedule is represented. The model is a planning pattern, not an operational commitment.

Public evidence

What the company context supports—and what it does not.

Sources establish the public process architecture. They do not reveal private operating parameters, site performance or an Acatian relationship.
  1. Lonza — Integrated Biologics 2025Public reactor scales and flexible multi-product campaign context.
  2. Lonza — One Lonza strategyPublic multi-modality and network context.

Frequently asked questions

Practical modelling questions

Is this the named organisation's real plant model?

No. It is an independent hypothetical Acatian study based only on the cited public process architecture. It claims no affiliation, endorsement, deployment, confidential data or actual plant performance.

Where do the numerical inputs come from?

Every input must be marked as a public fact, literature estimate, transparent engineering assumption or authorised customer input. The public article does not invent private operating values.

Can the model be calibrated to a real facility?

Yes, when the operator supplies authorised process, equipment, schedule and utility evidence and agrees the intended use, acceptance criteria and validation plan.

Related engineering guides

Continue through the connected model.

Bring one real process question

Build a model your technical team can inspect, challenge and improve.

Start with customer-owned data, explicit acceptance criteria and a clearly bounded engineering decision.